Brand Name

Not specified
Dosage Form

Not specified
Strength

Not specified

Manufacturer

Not specified
Conditions Studied
  • Medication was protected from light
  • Procedure A: 30 days at 50 degrees C and 100% relative humidity
  • Procedure B: 30 days at 50 degrees C and 100% relative humidity followed by 5 days at 70 degrees C and 100% relative humidity
Temperature (degrees Celsius)

50, 70
Humidity (%)

100
Countries Studied In

Not applicable (lab experiment)
Definition of Stability
  • A standard for a degraded sample was created that contained 10% degradation products and 90% of the label.
  • This standard was used to compare to the tested product during analytical testing.
Conclusions and Length of Stability
  • Author's conclusions: This medication was resistant to degradation under the conditions studied.
Reference
http://apps.who.int/medicinedocs/en/d/Jh1808e/

MeSH entry terms
  • Acids, Aminocaproic
  • Aminocaproic Acid
  • Acid, Aminocaproic
  • Caproamin
  • Rottapharm Brand of Aminocaproic Acid
  • Caprolest
  • Pharmachemie Brand of Aminocaproic Acid
  • Hemocaprol
  • Delagrange Brand of Aminocaproic Acid
  • Hexalense
  • Leurquin Brand of Aminocaproic Acid
  • Capralense
  • Sanofi Winthrop Brand of Aminocaproic Acid
  • Capramol
  • EAC
  • Berlin-Chemie Brand of Aminocaproic Acid
  • Berlin Chemie Brand of Aminocaproic Acid
MeSH reference: http://www.ncbi.nlm.nih.gov/mesh/68000614

Written by: Alex Evans, PharmD
Reviewed by:Last updated: June 9, 2013